Microbot Medical, Inc. Common Stock (MBOT) is a publicly traded Healthcare sector company. As of October 20, 2026, MBOT trades at $1.00 with a market cap of $63.81M and a P/E ratio of -3.74. MBOT moved +3.81% today. Year to date, MBOT is -54.84%; over the trailing twelve months it is -65.48%. Its 52-week range spans $0.93 to $4.67. Analyst consensus is strong buy with an average price target of $6.33. Rallies surfaces MBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MBOT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $63.81M |
| P/E Ratio | -3.74 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.67 |
| 52-Week Low | $0.93 |
| Volume | 282.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.14M |
| Gross Margin | 0.00% |
3 analysts cover MBOT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.33.